Skip to main content

Table 1 Baseline characteristics of patients

From: Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between Azelnidipine and amlodipine on Glucose tolerance and ENdothelial function - a crossover Trial (AGENT)

Male/female

11/6

Age, years

56 ± 13

Body mass index, kg/m 2

24.4 ± 4.0

Impaired glucose tolerance (%)

7 (41)

Dyslipidemia (%)

8 (47)

Current smoker (%)

3 (18)

History of CHD (%)

1 (6)

Hemoglobin A1c, % (JDS)

5.5 ± 0.4 (5.1 ± 0.3)

Fasting blood sugar, mg/dL

96 ± 8

Fasting IRI, μIU/mL

6.9 ± 4.2

eGFR, ml/min/1.73 m 2

83.2 ± 18.3

Medications

 

   ACE-inhibitor (%)

1 (6)

   ARB (%)

4 (24)

   Beta-blocker (%)

1 (6)

   Diuretics (%)

0 (0)

   Statin (%)

2 (12)

  1. Data are mean ± SD or numbers. CHD; coronary heart disease, JDS; Japan Diabetes Society, IRI; immunoreactive insulin, eGFR: estimated glomerular filtration rate; ACE; angiotensin converting enzyme, ARB; angiotensin-receptor blockers.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840